199 related articles for article (PubMed ID: 31103821)
1. Involvement of microRNA-23b-5p in the promotion of cardiac hypertrophy and dysfunction via the HMGB2 signaling pathway.
Boureima Oumarou D; Ji H; Xu J; Li S; Ruan W; Xiao F; Yu F
Biomed Pharmacother; 2019 Aug; 116():108977. PubMed ID: 31103821
[TBL] [Abstract][Full Text] [Related]
2. MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17.
Shi H; Li H; Zhang F; Xue H; Zhang Y; Han Q
Cell Biol Int; 2021 Nov; 45(11):2357-2367. PubMed ID: 34370360
[TBL] [Abstract][Full Text] [Related]
3. MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway.
Chen F; Li W; Zhang D; Fu Y; Yuan W; Luo G; Liu F; Luo J
Eur J Histochem; 2022 Jun; 66(3):. PubMed ID: 35726535
[TBL] [Abstract][Full Text] [Related]
4. microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis.
Li Y; Zhang H; Li Z; Yan X; Li Y; Liu S
BMC Cardiovasc Disord; 2021 Mar; 21(1):121. PubMed ID: 33658008
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
6. Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.
Pan J; Xu Z; Guo G; Xu C; Song Z; Li K; Zhong K; Wang D
Bioengineered; 2021 Dec; 12(1):5373-5385. PubMed ID: 34468254
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
8. miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1).
Ding Y; Wang J; Lu J
Bioengineered; 2021 Dec; 12(1):6771-6781. PubMed ID: 34515612
[TBL] [Abstract][Full Text] [Related]
9. MiR-338-5p ameliorates pathological cardiac hypertrophy by targeting CAMKIIδ.
Li K; Lin Y; Li C
Arch Pharm Res; 2019 Dec; 42(12):1071-1080. PubMed ID: 31820396
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T
J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
12. SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.
Long Y; Wang L; Li Z
J Cell Mol Med; 2020 Jul; 24(13):7115-7126. PubMed ID: 32436661
[TBL] [Abstract][Full Text] [Related]
13. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Lu Y; Wu F
Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
[TBL] [Abstract][Full Text] [Related]
15. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
[TBL] [Abstract][Full Text] [Related]
16. miR-200a-5p augments cardiomyocyte hypertrophy induced by glucose metabolism disorder via the regulation of selenoproteins.
Yang T; Liu T; Cao C; Xu S
J Cell Physiol; 2019 Apr; 234(4):4095-4103. PubMed ID: 30144391
[TBL] [Abstract][Full Text] [Related]
17. MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR.
Zeng J; Wang L; Zhao J; Zheng Z; Peng J; Zhang W; Wen T; Nie J; Ding L; Yi D
Hum Cell; 2021 Sep; 34(5):1388-1397. PubMed ID: 34138410
[TBL] [Abstract][Full Text] [Related]
18. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
Xu X; Wang J; Wang X
Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
[TBL] [Abstract][Full Text] [Related]
19. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.
Li H; Xu JD; Fang XH; Zhu JN; Yang J; Pan R; Yuan SJ; Zeng N; Yang ZZ; Yang H; Wang XP; Duan JZ; Wang S; Luo JF; Wu SL; Shan ZX
Cardiovasc Res; 2020 Jun; 116(7):1323-1334. PubMed ID: 31397837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
